Dr. Soliman Abdel Kader Fakeeh Hospital Co. announces its Interim Financial results for the Period Ending on 2025-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 701.02 | 680.33 | 3.041 | 742.68 | -5.609 |
| Gross Profit (Loss) | 176.14 | 188.58 | -6.596 | 164.76 | 6.907 |
| Operational Profit (Loss) | 76.98 | 105.1 | -26.755 | 72.24 | 6.561 |
| Net profit (Loss) | 67.35 | 60.7 | 10.955 | 68.39 | -1.52 |
| Total Comprehensive Income | 67.35 | 60.7 | 10.955 | 49.74 | 35.404 |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 3,019.85 | 1,092.98 | 176.295 |
| Profit (Loss) per Share | 0.31 | 0.36 | |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Thousands) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Group revenue for 1Q-2025 reached SAR 701.0 million, recording a 3.0% year-on-year increase despite the prolonged impact of Ramadan and Eid Al Fitr holidays that led to the loss of the equivalent of seven working days in 1Q-2025 compared to 1Q-2024. Growth during the quarter was supported by an increase in patient volumes and a Group-wide improvement in business mix with enhanced average revenue per patient. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | The Group’s Net Profit for the quarter reached SAR 67.4 million in 1Q-2025, up 11.0% y-o-y with net profit margin expanding by c.70 bps to 9.6%compared to the 8.9% in Q1-2024. Bottom-line profitability was driven by top line growth coupled with lower net financing costs.
The Group’s EBITDA recorded SAR 121.1 million in 1Q 2025 with an EBITDA margin of 17.3% compared to 21% in 1Q-2024, reflecting the impact of Ramadan and Eid holiday as well as pre-operating expenses related to the Group’s expansions. It is worth noting that the Group’s EBITDA calculation excludes SAR 2.3 million related to the non-cash Long-term Incentive Plan (LTIP) that started to accrue for qualified employees in 1Q-2025. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Group revenue in Q1-2025 was SAR 701.0 million, lower by 5.6% from Q4-2024, reflecting the impact of Ramadan and Eid Holiday on patients served and elective procedures conducted. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | The Group’s Net profit for Q1 -2025 was SAR 67.4 million; decreasing by 1.5% compared to 4Q-2024 as a result of Ramadan and Eid holiday that impacted revenues on the back of less working days. However, on the back of the Group's operational optimization efforts and streamlining of service provision, the Group's profitability margin expanded from 9.2% in Q4-2024 to 9.6% in Q1-2025.
As a result of the Group's efficiency optimization efforts coupled with non-recurrence of material one-off expenses that were previously incurred in 4Q-2024, EBITDA expanded to SAR 121.1 million from SAR 117.9 million in 4Q-2024 with EBITDA margin increasing to 17.3% from 15.9%. The Group's EBITDA calculation adjusts for SAR 2.3 million related to the non-cash long-term incentive plan (LTIP) that began accruing for qualified employees from Q1-2025. |
| Statement of the type of external auditor's report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | NA |
| Reclassification of Comparison Items | Certain comparative figures have been reclassified, wherever considered necessary, for the purpose of comparison and better presentation. |
| Additional Information | NA |
| Attached Documents |
Comments